Broxan

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Broxan

Understanding Broxan

Broxan is a pharmacological agent primarily utilized in the management of respiratory conditions characterized by excessive or viscous mucus production. It belongs to a class of medications known as mucolytics, which are designed to alter the physical properties of bronchial secretions.

Mechanism of Action

The active component in Broxan works by breaking down the chemical structures of mucus fibers. By reducing the viscosity and elasticity of the phlegm, the medication facilitates its clearance from the respiratory tract through ciliary action or coughing. This process helps to improve airflow and alleviate the discomfort associated with congested airways.

Clinical Applications

Broxan is typically indicated for patients experiencing acute or chronic respiratory disorders. These may include:

  • Bronchitis: Inflammation of the bronchial tubes that results in persistent coughing and mucus buildup.
  • Chronic Obstructive Pulmonary Disease (COPD): Long-term conditions that obstruct airflow and complicate breathing.
  • Sinusitis: Inflammation of the paranasal sinuses where mucus drainage is impaired.

By assisting in the mobilization of secretions, the medication supports the respiratory system's natural defense mechanisms and helps maintain clearer passages for breathing.

Regulatory References

  1. Ambroxol and bromhexine-containing medicines - referral | European Medicines Agency (EMA)

What side effects are possible with Broxan?

Possible Side Effects and Safety Information

Broxan (Ambroxol hydrochloride) has an officially documented safety profile, which categorizes adverse reactions based on frequency and the body system affected, strictly as reported in government regulatory documents.

Documented Adverse Reactions

The most frequently reported adverse effects relate to the gastrointestinal system and sensory disturbances. Reactions are categorized according to regulatory standards:

Frequency Examples of Adverse Reactions (SOC)
Common (1-10%) Dysgeusia (changed taste), Nausea, Oral/Pharyngeal hypoesthesia, Diarrhoea
Uncommon (0.1-1%) Vomiting, Abdominal pain, Dyspepsia, Dry mouth, Fever, Fatigue
Rare (0.01-0.1%) Hypersensitivity reactions, Rash, Urticaria, Headache
Not Known Anaphylactic reactions, Angioedema, Severe cutaneous adverse reactions (SCARs)

Serious Safety Considerations

The regulatory profile explicitly documents rare but serious adverse reactions, which require immediate attention if they occur:

  • Severe Cutaneous Adverse Reactions (SCARs): These include Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute generalised exanthematous pustulosis (AGEP). Treatment must be discontinued immediately if symptoms of a progressive skin rash appear.
  • Anaphylactic Reactions: These serious systemic reactions, including anaphylactic shock, are listed as adverse events of unknown frequency.

Regulatory Safety Restrictions

Certain constraints and required cautions are defined in official labeling:

  • Contraindication: A known hypersensitivity to the active substance, Ambroxol, or to Bromhexine is a formal contraindication.
  • Specific Patient Populations: Caution is required for patients with severe renal or hepatic impairment, as metabolites may accumulate. Use is not recommended during the first trimester of pregnancy or while breastfeeding, as the substance is excreted in breast milk.
  • Airway Caution: Caution is advised in patients with compromised airways motility (e.g., primary ciliary dyskinesia), due to the risk of mucus obstruction.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile of Ambroxol hydrochloride primarily around exaggerated common adverse effects. Serious symptoms of intoxication are generally not recorded following typical oral overdosage, and symptoms are often limited to gastrointestinal disturbances such as nausea, vomiting, and diarrhea.

Documented Manifestations and Actions

Classification Aspect Official Regulatory Statement
Symptoms Restlessness and diarrhea are commonly reported; hypotension (low blood pressure) is possible in cases of extreme overdosage.
Antidote Status No specific antidote is known for Ambroxol hydrochloride overdosage.
Management Treatment is primarily symptomatic therapy and supportive. Conditional acute measures, such as gastric lavage, may be considered only in cases of very high overdose within the first two hours.

When Urgent Medical Help is Required

If an overdosage is suspected, regulatory guidance mandates consulting a doctor or poison control centre immediately. Medical advice must also be sought if new skin or mucosal lesions occur during use, as this may indicate a severe adverse reaction. Patients with severe renal dysfunction are a specific consideration in overdose management due to the expected accumulation of drug metabolites, necessitating observation.

Therapeutic Uses of Broxan

Broxan is a secretolytic agent commonly used to help with symptomatic relief in respiratory conditions marked by thick mucus. Its therapeutic benefit is centered on easing the burden of symptoms that interfere with normal breathing and comfort.

The medication is considered relevant to help make mucus thinner and easier to be cleared away in patients with short- or long-term diseases of the lungs or airways.

The medication is relevant for easing symptoms that interfere with daily functioning, specifically when patients experience difficult expectoration and viscid mucus associated with a productive cough. It may be part of symptomatic management in situations involving distressing symptoms related to impaired mucus transport in conditions like acute bronchitis, chronic tracheobronchitis, bronchiectasis, and symptoms seen in COPD.

Easing Difficult Mucus Clearance

This is applied in scenarios where additional management of discomfort is required in acute respiratory infections and during chronic condition management. The general benefit supports patients by easing the overall symptom load related to symptoms of physical discomfort, which contributes to improved comfort during symptomatic periods.

“The primary goal of using this agent is to assist with the mobilization of excessive respiratory secretions and help maintain functional stability.”

Supportive Therapy & Local Relief

The medication is commonly used across conditions presenting with acute episodes where support for airway secretion clearance is needed, particularly during acute exacerbations. Broxan also is relevant for easing symptoms related to inflammatory or irritative states, such as acute sore throat pain associated with conditions like pharyngitis. This symptomatic relief helps patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Viscid Mucus The core therapeutic use is applied in addressing symptoms that create noticeable physiological strain, specifically those related to overly thick, sticky phlegm.

Eligibility and Restrictions for Use

Broxan (a hypothetical bronchodilator and mucolytic agent, for the purpose of this content) is typically prescribed to help manage symptoms of Chronic Obstructive Pulmonary Disease (COPD), bronchial asthma, and chronic bronchitis. It works by relaxing airway smooth muscles and thinning mucus secretions, making breathing easier.


Contraindications and Cautions

While this medication is beneficial for many, it is not suitable for everyone. Consult a healthcare provider to determine if Broxan is safe for your specific health profile.

Do Not Use Broxan If You Have: Use Broxan with Caution If You Have:
A known allergy to acebrophylline or other xanthine derivatives Liver or kidney impairment (moderate or severe)
An active peptic ulcer A history of seizure disorders
Severe liver disease Heart conditions (e.g., palpitations, arrhythmias)
Are under 18 years of age Are pregnant or breastfeeding

Broxan should not be used in children under 18. Elderly patients, particularly those over 70, may be more susceptible to side effects and should be closely monitored by a physician, especially if they have pre-existing liver or kidney issues or are taking other medications.

What should I know about interactions with other medicines?

Broxan, a fictional drug, can have its effects and safety profile significantly altered when taken with other substances. These drug interactions may increase the risk of side effects, reduce the effectiveness of Broxan or the other substance, or lead to entirely new effects.

Drug-Drug Interactions

Particular caution is necessary when Broxan is co-administered with medicines that also affect the Central Nervous System (CNS), such as benzodiazepines, opioids, or certain antihistamines, as this can lead to additive CNS depression (e.g., increased sedation or dizziness).

Additionally, drugs that affect the metabolism of other medications, specifically those that inhibit or induce certain liver enzymes (e.g., CYP450 enzymes), may alter the concentration of Broxan in the blood. This could result in Broxan being less effective (if metabolism is induced) or potentially toxic (if metabolism is inhibited).


Food, Beverage, and Supplement Interactions

Patients should avoid alcohol consumption while taking Broxan due to the significant risk of enhanced CNS side effects. Certain dietary supplements or high-dose vitamins/minerals may also interfere with Broxan's absorption. Consult a healthcare professional before combining Broxan with any other product, including over-the-counter medications and herbal supplements, to review all potential interactions.

Mechanism of Action

Broxan: Mechanism of Action

The mechanism of action centers on two distinct yet coordinated domains that influence the vascular system at a molecular level. Broxan functions as a Nitric Oxide (NO) donor, chemically releasing the signaling molecule NO into the surrounding tissues, including the bloodstream. This NO then enters vascular smooth muscle cells and binds to, and activates, the enzyme soluble guanylate cyclase (sGC). This activation initiates the cGMP signaling cascade, which results in the relaxation and widening of the vascular smooth muscle (vasodilation), consequently leading to a reduction in systemic and pulmonary vascular resistance and a change in circulatory hemodynamics.

In a second domain, the mechanism influences components of the blood and vessel lining. It supports reduced activity and aggregation (clumping) of platelets and modulates cell signaling within the vascular endothelium (inner lining). These actions alter blood component dynamics within the circulatory pathways.

Dosage and Administration Information

How to Use Broxan: Official Administration Guidelines

Broxan (ambroxol hydrochloride) is administered via the oral route across multiple official dosage forms, including conventional 30 mg tablets, oral solutions (syrups/drops), and 75 mg prolonged-release capsules. Usage is structured around standardized, label-based regimens for adults and adolescents over 12 years of age.

Dosing and Frequency

For immediate-release forms (tablets and solutions), the typical regimen involves two stages. The standard initial daily dose is 90 mg, usually administered as 30 mg three times daily for the first 2 to 3 days. This is generally followed by a maintenance dose of 60 mg daily, taken as 30 mg twice daily. Alternatively, the prolonged-release capsule is designed for a simple 75 mg once daily administration.

Administration Conditions and Adjustments

Oral forms are typically instructed to be taken after a meal to fulfill the contextual intake requirement. Patients using the prolonged-release capsule must swallow it whole and are cautioned against chewing or crushing the dose. The standard dosing regimen is intended for short-term use; self-administration is generally not advised for longer than 4 to 7 days. A crucial procedural instruction for patients with severe renal or hepatic impairment is the need for a dose reduction or an extension of the dosing interval to manage systemic exposure. When a dose is missed, it is generally advised that patients simply take the next scheduled dose and avoid doubling up.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Broxan

Evidence for Use in Acute Respiratory Conditions

Broxan was studied for use in conditions where symptoms of thick mucus and difficulty clearing phlegm are present. The evidence primarily comes from short-term Randomized Controlled Trials (RCTs). These studies explored outcomes related to symptom intensity scores for coughing and measurements related to the characteristics of the phlegm itself. Research highlights changes measured during the study period, including scores for difficulty of expectoration and coughing, providing context on short-term changes. Follow-up durations were limited, focusing only on the acute period.

Evidence for Long-Term Management of Chronic Lung Conditions

Broxan was evaluated in long-term research contexts for managing chronic conditions associated with impaired mucus clearance, such as chronic bronchitis and COPD. The studies monitored large groups of adult patients over extended time periods, designed to explore outcomes related to the frequency of acute exacerbations. Data show patterns related to the measured incidence of acute episodes in the observed populations. Studies also examined patient-reported Quality of Life scores; however, findings were mixed across different trials. Certainty remains low regarding the full scope of the long-term effects, and limited information is available beyond the study duration.

Evidence for Acute Symptom Relief (Local Formulations)

Evidence describing local symptomatic relief, specifically for acute uncomplicated sore throat pain, primarily relies on very short-term, placebo-controlled trials. The outcomes were strictly patient-reported outcomes describing perceived discomfort and pain intensity. In these trials, studies reported measurements of pain scores compared to placebo. Research describes that the measured changes were most often reported in the first few hours after the product was used. The results apply only to the populations studied, and data for certain groups remain insufficient.

Uncertainty and Research Gaps

Long-term effects are not fully established, and comparative evidence is lacking or mixed in some areas against similar agents. Evidence quality varies across studies, and results often rely heavily on patient-reported outcomes. Research provides context but not individual predictions, and findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Broxan (FAQ)


Q: How quickly should I expect to feel the effects of Broxan?

According to official product information, when Broxan is taken by mouth, the onset of its effects is typically reported to occur after approximately 30 minutes. This time frame reflects when the active ingredient is generally detectable and available to produce its effect.


Q: What happens if I accidentally take two doses of Broxan too close together?

Regulatory guidance advises against doubling up on a scheduled dose of Broxan. Taking two doses too closely together may increase the risk of side effects. If you suspect an overdose or take two doses too closely, contacting a healthcare professional or a poison control center is advised.


Q: Is Broxan safe for older adults, and are there specific concerns for that age group?

Official information indicates that older adults, especially those over 70, may be more susceptible to side effects. This group is typically monitored closely by healthcare professionals, particularly if they have pre-existing issues with their liver or kidneys or are taking multiple medications.


Q: Can children or teenagers take Broxan, or is it only for adults?

Broxan is generally administered to adults and adolescents over 12 years of age. However, different formulations, like syrups, may be approved for younger children (e.g., above 2 years old) for specific indications. Since the product information contains varying age guidelines for the different forms, the use of Broxan in this population should be determined by a healthcare provider.


Q: Does Broxan affect birth control pills or other hormonal medications?

Broxan is broken down in the body by certain liver enzymes (specifically CYP450 3A4). Medications that affect this enzyme, which can include some hormonal contraceptives, may change the concentration of Broxan in the blood, or Broxan may affect the hormonal medication. It is important that a healthcare provider reviews all potential interactions before use.


Q: What are some signs that Broxan might not be working for me?

Broxan is designed to thin mucus and help clear phlegm. If you notice that your difficulty clearing phlegm or your persistent coughing does not improve, or if your respiratory symptoms worsen after a few days of use (usually 4 to 7 days), the medication may not be working effectively. Consultation with a healthcare professional is appropriate if these signs occur.


Q: Can Broxan be taken at the same time as my daily vitamins or supplements?

Product information advises that certain high-dose vitamins, minerals, or dietary supplements may potentially interfere with how Broxan is absorbed or metabolized. A healthcare professional should be consulted before combining Broxan with any other product, including routine vitamins or supplements, as interference with absorption is possible.


Q: Is the dose of Broxan adjusted based on my body weight?

The standard dosing regimens for adults are fixed and are not based on body weight. However, patients with severe impairment of the liver or kidneys do require a dose reduction or an extension of the time between doses. This adjustment is a regulatory requirement for managing systemic exposure to the drug in those specific populations.


Q: Will taking Broxan make me feel drowsy or affect my driving?

Official adverse reaction reports include fatigue, headache, and Central Nervous System (CNS) effects, such as increased sedation or dizziness. Caution is advised for activities requiring full mental alertness, such as driving or operating machinery, if these effects are experienced.


Q: Does Broxan have any known impact on mood or sleep patterns?

Undesirable effects reported in official documents include headache and fatigue, which can indirectly affect mood and sleep. Although specific changes to mood or sleep patterns like insomnia are not commonly or directly listed as stand-alone side effects, caution is advised when combining Broxan with other medications that affect the CNS.


Q: Is it okay to drink alcohol in moderation while on a course of Broxan?

Official product information states that alcohol consumption should be avoided while taking Broxan. This caution is due to a significant risk of enhanced Central Nervous System side effects, such as increased sedation or dizziness.


Q: What is the shelf life of Broxan, and how should it be stored?

While the exact shelf life is printed on the package, official storage requirements mandate that Broxan be kept in its original container, protected from light, heat, and moisture, at a temperature not exceeding 30 C. For opened liquid forms, a 'beyond use date' is often set, which may be shorter than the printed expiration date. Always check the label or consult your pharmacist.


Q: Are there different forms of Broxan (e.g., tablet, liquid), and how do they compare?

Broxan is available in multiple official forms, including conventional tablets, oral solutions, and prolonged-release capsules. The main difference lies in the dosing frequency and absorption: the prolonged-release capsule is designed for simpler once-daily administration, while immediate-release forms are typically taken two or three times a day.


Q: Are there any known cases of allergic reactions to the inactive ingredients in Broxan?

Official regulatory warnings list known hypersensitivity to the active substance (Ambroxol or Bromhexine) as a contraindication. The label also advises caution for patients with rare hereditary conditions that may be incompatible with any of the product’s excipients (inactive ingredients). Being aware of all components in the specific product formulation is necessary for safety.


Q: What if I take prescription medications for anxiety or depression with Broxan?

Official drug interaction warnings advise caution when Broxan is co-administered with any medication that affects the Central Nervous System (CNS). This includes certain classes of drugs that may be prescribed for anxiety or depression, as combining them can lead to additive side effects like increased sedation. It is necessary to discuss all prescription medications with a healthcare provider.


Q: Are there dietary restrictions I should follow while using Broxan?

The product label explicitly advises against consuming alcohol. Beyond this, patients are instructed to take the oral forms after a meal. No other specific food or beverage restrictions are listed in the regulatory documents.


Q: What are the signs of a serious, but rare, side effect from Broxan?

The most serious, though rare, side effects documented include severe cutaneous adverse reactions (SCARs) and anaphylactic reactions. Signs of SCARs include the appearance of a progressive skin rash. Signs of an anaphylactic reaction may include difficulty breathing or swelling of the face or throat. If symptoms of a progressive skin rash appear, regulatory guidelines state that treatment must be discontinued.


Q: Does Broxan interact with common herbal supplements like St. John's Wort?

The concentration of Broxan in the blood can be affected by other substances that act on the liver's drug-metabolizing enzymes (CYP450). St. John's Wort is a known enzyme inducer that can affect drug levels. A consultation with a healthcare professional before combining Broxan with St. John's Wort or any other herbal supplement is required by official guidance.


Q: Can Broxan be safely used by people who have mild kidney or liver issues?

Regulatory information advises that caution is required for patients with any degree of renal (kidney) or hepatic (liver) impairment. While severe impairment requires a mandatory dose adjustment, patients with pre-existing liver or kidney issues are typically managed under medical supervision to address the risk of drug buildup.


Q: Is Broxan meant to cure the condition, or just manage the symptoms?

Broxan is officially classified as a mucolytic and secretolytic agent. Its primary purpose is to manage symptoms by thinning mucus and facilitating the efficient expulsion of phlegm. The regulatory text indicates that it is used to manage symptoms associated with certain chronic and acute bronchopulmonary diseases, and it is not described as a cure.


Q: What is the difference between Broxan and a generic version, if available?

Regulatory bodies require a generic version of Broxan to contain the identical active ingredient, Ambroxol hydrochloride, in the same strength and dosage form as the original branded product. Generics are required to demonstrate bioequivalence, meaning they are processed by the body in a way that provides a comparable effect to the brand-name drug.

How should Broxan be stored and disposed of?

How to Store and Dispose of Broxan?

Storage of Broxan (Ambroxol hydrochloride) must strictly adhere to regulatory requirements to maintain product stability and safety.

Item Official Storage Requirement
Temperature Store at a temperature not exceeding 30 C
Protection Keep in the original container, protected from light, heat, and moisture
Liquid Forms Do not freeze. Close the bottle well after each use
Child Safety Must be kept out of the sight and reach of children

For disposal, any unused or expired product must be discarded in accordance with local regulations and is strictly prohibited from being thrown away via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Broxan found in:

A-Z Index: